This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Long Term Evaluation of Sarilumab in Rheumatoid Ar...
Clinical trial

Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)

Read time: 1 mins
Last updated:1st Jun 2010

Primary Objective:
- Assess the long term safety of sarilumab in patients with rheumatoid arthritis.

Secondary Objective:
- Assess the long term efficacy of sarilumab in patients with rheumatoid arthritis.


Study Type: Interventional
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Multi-center, Uncontrolled Extension Study Evaluating Efficacy and Safety of SAR153191 in Patients With Active Rheumatoid Arthritis (RA)
Estimated Enrollment: 2000
Study Start Date: June 2010
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)

Arms:
- Experimental:
Extension study

Category Value
Study start date 2010-06-01

View full details